Woodline Partners »

Benitec Biopharma shares owned by Woodline Partners

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 101k 13.47

More positions owned by Woodline Partners

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Verizon Communications (VZ)
Revolution Medicines (RVMD)

View all positions for Woodline Partners

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
Vanguard Group
Nantahala Capital Management
BlackRock
Infinitum Asset Management
Siren
Alyeska Investment Group
Silverarc Capital Management
Geode Capital Management
AWM Investment Company
Schonfeld Strategic Advisors
State Street Corporation

View all funds holding Benitec Biopharma